Lapatinib

Records for this ingredient, by country (identity only).

ATC L01EH01 · 9 markets · 14 records

Lapatinib 9 markets · 14 records Forms

Filters

MarketHK 4 ES 2 GB 1 AU 1 CN 1 JP 1 EU 1 FR 1

Strength

HK 4 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Lapatinib ×5LAPATINIB STADA ×2TYKERB ×12

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

ES 2 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

250 mgtabletLAPATINIB STADA+1Tyverb 250mg tablets also in GB·AU·CN
+2Other 2 markets
JP FR

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

250 mgtabletTyverb 250mg tablets also in ES·AU·CN
+2Other 2 markets
JP FR

AU 1 records · 1 shown of 1 Source PBS Schedule API v3 (Department of · Data as of 2026-10-01

250 mgtabletTYKERB also in ES·GB·CN
+2Other 2 markets
JP FR

CN 1 records · 1 shown of 1 Source 国家医保局医保药品分类与代码数据库 · Data as of 2025-04-04

250 mgtablet泰立沙拉帕替尼 also in ES·GB·AU
+2Other 2 markets
JP FR

JP 1 records · 1 shown of 1 Source 厚生労働省薬価基準収載品目リスト · Data as of 2026-11-01

250 mgtabletタイケルブ錠250mg also in ES·GB·AU
+2Other 2 markets
CN FR

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Tyverb 250mg tablets ×3

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

250 mgtabletTYVERB 250 mg, comprimé pelliculé also in ES·GB·AU
+2Other 2 markets
CN JP

Side-by-side table

Strength / form / release	GB	AU	CN	ES	HK	JP	EU	FR
250 mgRecorded as: 0.25 g tablet	Tyverb 250mg tablets	TYKERB	泰立沙拉帕替尼	LAPATINIB STADA Tyverb 250mg tablets	not recorded	タイケルブ錠250mg	not recorded	TYVERB 250 mg, comprimé pelliculé
not disclosed unknown	not recorded	not recorded	not recorded	not recorded	Lapatinib LAPATINIB STADA TYKERB	not recorded	Tyverb 250mg tablets	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

Also called: 甲苯磺酸拉帕替尼 nickname

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.